glp-1 news 2025 october 16 What's next for innovation: A primer on the race reshaping pharma and chronic disease care Mapping the effectiveness and risks

Your provider will recommend the appropriate starting dose and adjust gradually based on your response and lab monitoring to support safe, sustainable progress

Consider supplementation

11 Low B12 can dampen memory, choline deficiency can dull focus, and inadequate omega3s can interfere with mood regulation so what may seem like a side effect of the drug could actually stem from underlying nutritional gaps

Among the GLP-1 medications included in this study, the authors found semaglutide showed a stronger association with reduced AFib risk than liraglutide, dulaglutide and tirzepatide.

Drug Shortage Status The FDA declared the tirzepatide shortage resolved in October 2024 and the semaglutide shortage resolved in February 2025